The Spain peptide anticoagulant drugs market growth is charting an impressive trajectory as the convergence of artificial intelligence, computational chemistry, and structural biology creates unprecedented opportunities for rational design of peptide anticoagulants with optimized target binding, reduced immunogenicity, and favorable pharmacokinetic profiles. Spanish research institutions...